Clinical trial
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
NCT00354484 · American Regent, Inc., Industry · Completed
Key facts
| NCT number | NCT00354484 |
|---|---|
| Title | Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients |
| Official title | Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients |
| Lead sponsor | American Regent, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postpartum Anemia |
| Intervention type | Drug |
| Interventions | Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets |
| Enrollment | 291 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | Feb 20, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: